BR112012030652A2 - comprimidos que podem ser dispersos oralmente de eritritol e isomalte - Google Patents
comprimidos que podem ser dispersos oralmente de eritritol e isomalteInfo
- Publication number
- BR112012030652A2 BR112012030652A2 BR112012030652A BR112012030652A BR112012030652A2 BR 112012030652 A2 BR112012030652 A2 BR 112012030652A2 BR 112012030652 A BR112012030652 A BR 112012030652A BR 112012030652 A BR112012030652 A BR 112012030652A BR 112012030652 A2 BR112012030652 A2 BR 112012030652A2
- Authority
- BR
- Brazil
- Prior art keywords
- tablets
- seconds
- isomalt
- erythritol
- orally
- Prior art date
Links
- SERLAGPUMNYUCK-DCUALPFSSA-N 1-O-alpha-D-glucopyranosyl-D-mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-DCUALPFSSA-N 0.000 title abstract 3
- 239000004386 Erythritol Substances 0.000 title abstract 3
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 title abstract 3
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 title abstract 3
- 235000019414 erythritol Nutrition 0.000 title abstract 3
- 229940009714 erythritol Drugs 0.000 title abstract 3
- 235000010439 isomalt Nutrition 0.000 title abstract 3
- 239000000905 isomalt Substances 0.000 title abstract 3
- HPIGCVXMBGOWTF-UHFFFAOYSA-N isomaltol Natural products CC(=O)C=1OC=CC=1O HPIGCVXMBGOWTF-UHFFFAOYSA-N 0.000 title abstract 3
- 239000003826 tablet Substances 0.000 abstract 4
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 238000007906 compression Methods 0.000 abstract 1
- 230000006835 compression Effects 0.000 abstract 1
- 239000007919 dispersible tablet Substances 0.000 abstract 1
- 239000008187 granular material Substances 0.000 abstract 1
- 238000005469 granulation Methods 0.000 abstract 1
- 230000003179 granulation Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000010998 test method Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Fodder In General (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP10005677 | 2010-06-01 | ||
| PCT/EP2011/002432 WO2011151018A2 (en) | 2010-06-01 | 2011-05-17 | Orodispersible tablets of erythritol and isomalt |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112012030652A2 true BR112012030652A2 (pt) | 2016-08-16 |
Family
ID=42735711
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112012030652A BR112012030652A2 (pt) | 2010-06-01 | 2011-05-17 | comprimidos que podem ser dispersos oralmente de eritritol e isomalte |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20130072578A1 (https=) |
| EP (1) | EP2575755A2 (https=) |
| JP (1) | JP5902677B2 (https=) |
| KR (1) | KR20130086159A (https=) |
| CN (1) | CN102905691A (https=) |
| BR (1) | BR112012030652A2 (https=) |
| CA (1) | CA2800266A1 (https=) |
| MX (1) | MX2012013759A (https=) |
| WO (1) | WO2011151018A2 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6012373B2 (ja) * | 2012-09-28 | 2016-10-25 | 杏林製薬株式会社 | 口腔内崩壊錠 |
| JP7486258B2 (ja) * | 2019-12-26 | 2024-05-17 | 物産フードサイエンス株式会社 | 口腔内崩壊錠用顆粒、その製造方法および口腔内崩壊錠 |
| CN112137097A (zh) * | 2020-10-10 | 2020-12-29 | 广东青云山药业有限公司 | 一种口腔速溶颗粒及其制备方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69738829D1 (de) * | 1996-07-12 | 2008-08-21 | Daiichi Seiyaku Co | Schnell zerfallende, druckgeformte Materialien sowie Prozess zu deren Herstellung |
| JPH10182436A (ja) * | 1996-10-31 | 1998-07-07 | Takeda Chem Ind Ltd | 固形医薬製剤 |
| WO2006002937A1 (en) * | 2004-07-01 | 2006-01-12 | Lek Pharmaceuticals D.D. | Rapidly disintegrating orodispersible composition containing nonfilamentous coprocessed polyols particles and silicified microcrystalline cellulose |
| JP2008037853A (ja) * | 2006-08-01 | 2008-02-21 | Higuchi Shokai:Kk | イソマルトを含有する速崩壊性医薬品固形製剤 |
| EP2264042B1 (en) | 2007-07-27 | 2012-07-18 | Cargill, Incorporated | Micronization of polyols |
| EP2153822A1 (en) * | 2008-08-13 | 2010-02-17 | Lek Pharmaceuticals D.D. | Granulation of active pharmaceutical ingredients |
| FR2933299B1 (fr) | 2008-07-04 | 2012-02-03 | Roquette Freres | Mannitol orodispersible |
| WO2010025796A1 (en) * | 2008-09-04 | 2010-03-11 | Cargill Incorporated | Tabletting of ervthritol |
| PT2358374E (pt) * | 2008-11-17 | 2013-12-09 | Takeda Nycomed As | Estabilidade de dissolução melhorada de comprimidos de carbonato de cálcio |
-
2011
- 2011-05-17 BR BR112012030652A patent/BR112012030652A2/pt not_active IP Right Cessation
- 2011-05-17 JP JP2013512780A patent/JP5902677B2/ja not_active Expired - Fee Related
- 2011-05-17 MX MX2012013759A patent/MX2012013759A/es not_active Application Discontinuation
- 2011-05-17 KR KR1020127034435A patent/KR20130086159A/ko not_active Ceased
- 2011-05-17 US US13/701,051 patent/US20130072578A1/en not_active Abandoned
- 2011-05-17 CA CA2800266A patent/CA2800266A1/en not_active Abandoned
- 2011-05-17 EP EP11721714.1A patent/EP2575755A2/en not_active Withdrawn
- 2011-05-17 WO PCT/EP2011/002432 patent/WO2011151018A2/en not_active Ceased
- 2011-05-17 CN CN2011800270378A patent/CN102905691A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2011151018A2 (en) | 2011-12-08 |
| KR20130086159A (ko) | 2013-07-31 |
| JP2013530163A (ja) | 2013-07-25 |
| JP5902677B2 (ja) | 2016-04-13 |
| MX2012013759A (es) | 2013-01-24 |
| CN102905691A (zh) | 2013-01-30 |
| WO2011151018A3 (en) | 2012-05-31 |
| US20130072578A1 (en) | 2013-03-21 |
| EP2575755A2 (en) | 2013-04-10 |
| CA2800266A1 (en) | 2011-12-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Late et al. | Effects of disintegration-promoting agent, lubricants and moisture treatment on optimized fast disintegrating tablets | |
| Saif et al. | Formulation and evaluation of trimetazidine hydrochloride and clopidogrel bisulphate multi-unit solid dosage forms | |
| BR112014018378A8 (pt) | Processo contínuo para a preparação de um comprimido compreendendo ácido 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol5-il) ciclopropanocarboxamido)-3-metilpiridin-2-il)benzoico | |
| Pathan et al. | Formulation design and optimization of novel mouth dissolving tablets for venlafaxine hydrochloride using sublimation technique | |
| BRPI0707044B8 (pt) | comprimido matricial insolúvel em água e processo de fabricação de comprimidos matriciais | |
| AR065096A1 (es) | Preparacion solida | |
| FI3182975T3 (fi) | Rukaparibin suuren annosvahvuuden tabletteja | |
| BR112014026292B1 (pt) | Comprimido oralmente desintegrável, e, processo para a produção de um comprimido oralmente desintegrável | |
| UA116334C2 (uk) | Тверді форми дозування бендамустину | |
| AR077546A1 (es) | Formulaciones de comprimidos de 3-cianoquinolina y usos de los mismos | |
| AR107391A1 (es) | Formulaciones / composiciones que comprenden un inhibidor de btk | |
| NO20082047L (no) | Sakte frigivende sammensetning, fremgangsmate for fremstilling derav og anvendelse av samme | |
| NO20090980L (no) | Kapecitabin pediatriske tabeletter | |
| AR100977A1 (es) | Formulación compuesta para la administración oral que comprende ezetimiba y rosuvastatina, y un proceso para su preparación | |
| JP2016108327A5 (https=) | ||
| AR061790A1 (es) | Composicion farmaceutica solida para la administracion oral, formulaciones de comprimidos de liberacion inmediata de un antagonista del receptor de trombina, y su uso en la manufactura de un medicamento | |
| BR112012030652A2 (pt) | comprimidos que podem ser dispersos oralmente de eritritol e isomalte | |
| BR112014026439A2 (pt) | comprimidos revestidos e produção dos mesmos | |
| Huynh et al. | Floating tablets incorporating curcumin solid dispersion as a potential pharmaceutical dosage form for stomach cancer treatment | |
| MY139086A (en) | Use of debranched starch in extrusion-spheronization pharmaceutical pellets | |
| BR112013022017A2 (pt) | formulação farmacêutica, comprimido, e, método para produzir uma formulação farmacêutica | |
| AR080895A1 (es) | Formulacion de comprimido de ezatiostat | |
| PE20160245A1 (es) | Composicion farmaceutica anti-tuberculosis estable en una forma de un comprimido dispersable que comprende granulos de isoniazid y granulos de rifapentina y su proceso de preparacion | |
| JP2019014666A5 (https=) | ||
| BR112015015483A2 (pt) | forma farmacêutica monolítica para a liberação modificada de uma combinação de ingredientes ativos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] | ||
| B350 | Update of information on the portal [chapter 15.35 patent gazette] |